MedCity News August 6, 2020
As we look forward to the back half of the year, it’s clear that the desire for companies to commence their IPO process with organizational meetings and bake-offs continues
As we cross the mid-point of 2020, the second quarter turned out to be the busiest quarter for biotech equity to date, and just two weeks into the third quarter, the IPO market is firing on all cylinders. Only a couple weeks into July, we’ve already seen IPOs by Relay Therapeutics, Pandion Therapeutics, Nkarta and Inventiva, and we continue to see issuers pushing to expeditiously get on file and take advantage of the investor receptiveness to biotech equity offerings.
The recent uptick in activity following the Covid-19 pandemic has brought about...
Today's Sponsors
Today's Sponsor